English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  51779705    ???header.onlineuser??? :  1154
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"pei jer chen"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 466-475 of 883  (89 Page(s) Totally)
<< < 42 43 44 45 46 47 48 49 50 51 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-07-03T03:34:26Z Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3 Chen K.-F.; Chen H.-L.; Liu C.-Y.; Tai W.-T.; Ichikawa K.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:26Z Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy Sheng W.-H.; Hung C.-C.; Chang S.-Y.; Liu C.-J.; Chen M.-Y.; Hsieh S.-M.; Kao J.-H.; PEI-JER CHEN; Chang S.-C.
臺大學術典藏 2021-07-03T03:34:25Z Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:25Z Re-evaluation of the Carcinogenic Significance of Hepatitis B Virus Integration in Hepatocarcinogenesis Jiang S.; Yang Z.; Li W.; Li X.; Wang Y.; Zhang J.; Xu C.; PEI-JER CHEN; Hou J.; McCrae M.A.; Chen X.; Zhuang H.; Lu F.
臺大學術典藏 2021-07-03T03:34:25Z Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia Afdhal N.H.; Giannini E.G.; Tayyab G.; Mohsin A.; Lee J.-W.; Andriulli A.; Jeffers L.; McHutchison J.; PEI-JER CHEN; Han K.-H.; Campbell F.; Hyde D.; Brainsky A.; Theodore D.
臺大學術典藏 2021-07-03T03:34:25Z Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells Chen K.-F.; Lin J.-P.; Shiau C.-W.; Tai W.-T.; Liu C.-Y.; Yu H.-C.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:24Z IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients Hsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen C.-L.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:24Z A systematic review and meta-analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma Huang T.-S.; Shyu Y.-C.; Chen H.-Y.; Yuan S.-S.; Shih J.-N.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:24Z Influences of tobacco and alcohol use on hepatocellular carcinoma survival Shih W.-L.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Liu C.-J.; Lin C.-L.; Yu M.-W.
臺大學術典藏 2021-07-03T03:34:23Z Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells Tai W.-T.; Shiau C.-W.; Chen H.-L.; Liu C.-Y.; Lin C.-S.; Cheng A.-L.; PEI-JER CHEN; Chen K.-F.

Showing items 466-475 of 883  (89 Page(s) Totally)
<< < 42 43 44 45 46 47 48 49 50 51 > >>
View [10|25|50] records per page